Advertisement

Overemphasis on Overdiagnosis

Published:November 02, 2015DOI:https://doi.org/10.1016/j.acra.2015.08.030
      It is disheartening to write this response to our own Academic Radiology. The commentary using the misnomer “Mammogram Trials” by Jha and Ware (
      • Jha S.
      • Ware J.B.
      Mammogram trials.
      ) describes only a single trial—the outlier—the only randomized controlled study (
      • Miller A.B.
      • Wall C.
      • Baines C.J.
      • et al.
      Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
      ) published that did not show a mortality benefit from screening mammography. Although experts in breast cancer and breast imaging would disagree with much of the article, the issue of overdiagnosis raised by Jha and Ware requires clarification.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jha S.
        • Ware J.B.
        Mammogram trials.
        Acad. Radiol. 2015; 22: 973-975
        • Miller A.B.
        • Wall C.
        • Baines C.J.
        • et al.
        Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
        BMJ. 2014; 348 (g366)
      1. International Agency for Research on Cancer Handbook on Cancer Prevention. 2002; 7: 144
        • Zackrisson S.
        • Andersson I.
        • Janzon L.
        • et al.
        Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study.
        BMJ. 2006; 332: 689-692
        • Duffy S.W.
        • Agbaje O.
        • Tabar L.
        • et al.
        Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
        Breast Cancer Res. 2005; 7: 258-265
        • Puliti D.
        • Duffy S.W.
        • Miccinesi G.
        • et al.
        Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
        J Med Screen. 2012; 19: 42-56
        • Tabar L.
        • Vitak B.
        • Chen T.H.
        • et al.
        Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
        Radiology. 2011; 260: 658-663
        • Smith R.A.
        • Duffy S.W.
        • Gabe R.
        • et al.
        The randomized trials of breast cancer screening: what have we learned?.
        Radiol Clin North Am. 2004; 42: 793-806